Idogen's Historical Milestones - Idogen
Idogen AB (publ) Corp. Reg. No.
Idogen publishes prospectus in connection with the forthcoming rights issue - Nordic Life Science – the leading Nordic life science news service
Idogen AB (publ) kommenterar handelsstoppet den 25 april 2019 - Idogen
Idogen AB Interim report Idogen AB Interim report
Idogen AB (publ) Org nr
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
40/20 – Information regarding the rights issue from Idogen AB
Annual Report
Idogen's cell technology successfully advanced to large-scale production - Idogen
Idogen%20Q1%20ENG - Idogen
Crown Princess and Prince Daniel visited Idogen - Idogen
Idogen's Historical Milestones - Idogen
PRESS RELEASE IDOGEN AB
Idogen's Historical Milestones - Idogen
Idogen extends the project portfolio to projects in autoimmune diseases - Idogen
niklas wallett - Idogen
Idogen's Historical Milestones - Idogen
Idogen's Historical Milestones - Idogen
Investors Home
Idogen handelsstoppad på Spotlight | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare
Idogen AB Interim report Idogen AB Interim report
Correction: Idogen AB Interim report January–September 2019 - Idogen
Idogen appoints Anders Karlsson as new CEO - Idogen
Annual Report
